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1. Executive Summary 
 
 
 The UK care home market generated revenues of £11.4 billion in 2008; the market is 
expected to grow at a healthy CAGR of 7.3% over the period 2008-GULYHQE\8.¶V
rapidly ageing population, consolidation and rising fee rates 
 The market is dominated by the private sector, which accounts for about 68% of the total 
market value, and about 74% of the total number of beds in the care home sector 
 Total number of beds in the UK care home market has witnessed a decline over the past 14 
years, primarily due to an over-expansion in the early 1990s; going forward it is expected to 
further reduce in the near term as the public sector aims to withdraw from bed supply 
 Currently the UK comprises 18,500 homes, dominated by the private sector (accounting for 
over 70% share), followed by the voluntary segment with about 19% share 
 The UK care home market is fairly consolidated at the top end, with the top five players 
accounting for about 22% of beds in 2008; however, at the bottom end, the market is highly 
fragmented, with a significant number of homes comprising only one or two beds 
 The top four players by number of beds include Southern Cross Healthcare Group, BUPA, 
Four Seasons Health Care, and Barchester Healthcare; in the voluntary sector Anchor Trust is 
the largest player, accounting for 6.4% of the total number of voluntary beds in 2007 
 In 2008, dementia care in care homes was worth £4.7bn (or 36% of the market). 
 
The old age demographic trends, high occupancy rates and rising cases of dementia indicate an 
attractive market in care homes. Since care homes are witnessing strong growth, they offer an 
opportunity for Pfizer to actively market its drugs to this sector. 
Additionally, as an unconventional diversification opportunity, care homes also offer opportunity 
to Pfizer as a strong topline growth/high EBITDA market sector. 
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2. Introduction 
 
The European teams within Pfizer are facing unprecedented challenges as they operate in a 
mature industry that is evolving, with many new challenges emerging. 
The nature of changes that are taking place within the pharmaceutical industry are resulting 
in a need for companies to formulate new strategies in order to compete effectively and 
efficiently in this changing landscape. 
Similar to other pharmaceutical companies, Pfizer is facing a drying up of its blockbuster 
drugs pipeline (which has in the past been a major source of revenue). In addition to this, 
with growing generic medications availability within the marketplace, this has resulted in a 
downward pressure on prices of prescription products, resulting in a lowering of the 
FRPSDQ\¶VDOUHDG\GHFOLQLQJmargins.  
 
Mindful of these challenges, the Established Products Business Unit commissioned a group 
of MBA students at the Nottingham University Business School to undertake a summer 
internship project.  
 
The key objective of the project was to identify whether there were any unmet needs in the 
marketplace, which could be fulfilled by Pfizer, through new service offerings to their clients. 
The project would also indicate, where possible, whether the services could be used to 
generate revenues for the Established Products division within Pfizer. The client wished the 
project to identify not only services serving unmet needs, EXW DOVR DGGLWLRQDO µEOXH-VN\¶
service ideas. 
 
During the same project, the Established Products Business Unit requested the team 
to look at the opportunity in nursing homes in France and UK. 
 
This report is an extension of the previous report in the way that it delves upon 
opportunity areas for Pfizer as a service provider. 
 
This individual report attempts to assess how the current conditions of the UK Care 
Homes market are an attractive opportunity for Pfizer. 
 
2.1. Research Question 
 
The core question this project was aiming to answer was: 
How is the UK Care Home market positioned as an opportunity for Pfizer? 
In order to understand the market, the following aspects have been looked at: 
 
 Understand the UK care home market, including key trends (growth rates, 
population, size of sites etc) 
 Understand competitive landscape in the UK care home market, and identify key 
operators in the space 
 Analyse key characteristics in the care home market, such as independent vs. large 
chains, and public vs. private providers 
 Profiles of key care homes in the UK 
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2.2. Project Limitations 
 
The project has been desktop research oriented and not based on existing knowledge of 
Pfizer's exposure to nursing/residential homes in the UK. In that way, the research study 
independent of Pfizer's specific internal strategic objectives only attempts to throw light on 
the potential of the market for Pfizer. 
 
 
3. Methodology 
Conducted secondary research to gain an understanding of the UK care homes market as well 
as the market for FM services provided in the sector. Secondary sources researched included 
the Internet, company reports, association websites, news search, magazines, and proprietary 
databases. The report looked at developing an understanding of the major segments in the 
care home sector, including competitive landscape, key players, and role of government in 
funding.  
In terms of the Care Home market, most of the required information was gathered through 
the secondary domain Including key trends in growth rates, population, and sites; key 
operators (including sites, and future growth plans); market shares of private, voluntary and 
public care homes; public and private care home splits; as well as legislative impacts 
Attempt was made to understand the medicines/drugs used by nursing homes by brand and 
by treatment. However, primary interviews targeted at the same did yield results as most of 
the service provider, which are private in nature, refused to share information on the same.  
Consequently, the report has restricted its scope to the market analysis of the care home 
market in the light of the background of elderly healthcare statistics.  
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4. Market Analysis  
 
4.1. Care Homes Market Definition 
 
The long-term care sector provides long-term residential or nursing home care to those with 
chronic disabilities or conditions, including geriatric and dementia patients, terminally ill 
patients and those who are physically disabled. The majority of long-term care in the UK is 
supplied by private operators.  
 Residential care homes are required only to have a qualified nurse available on call 
 Nursing homes typically care for those with greater medical needs, and are required 
to have 24-hour qualified nursing care available 
 Several care home facilities have dual registration to allow for the most cost-effective 
flexibility of care 
 
 
 
 
 
 
Source: Keynote (2008); Deloitte (2008) 
Care Homes in the UK 
Residential 
Homes 
Provide accommodation, 
meals and assistance with 
personal care such as, 
washing, dressing, and 
using the toilet 
Provide accommodation, 
meals and personal care, 
but also have qualified 
nurses in constant 
attendance  
Nursing Homes 
Local Authorities National Health 
Service 
Independent 
Private homes or 
homes run on 
voluntary aid 
Operated and funded 
by local authorities 
In addition to care 
homes, NHS also 
provides  
 elderly care places in  
some hospitals 
The care home sector provides long-term residential or nursing home care to those with chronic 
disabilities or conditions, including geriatric and dementia patients, terminally ill patients and those 
who are physically disabled 
Most care homes are for the elders (generally above 65 years of age and mostly disabled); others 
are for children and adults 
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The UK care home 
market is expected to 
grow at a CAGR of 7.3% 
over the period 2008 
2012, driven by an 
ageing society and 
increasing profitability. 
 
4.2. Care Homes Market Overview 
 
4.2.1. Care Homes Market Size 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: UK Private Healthcare, Keynote (2008) 
 
The UK care home market was valued at £12.7 billion in 2007, 
growing at a CAGR of 4.4% over the period 2003-2007, primarily 
due to unprecedented levels of investor activity over the period1. 
This has been driven by various factors such as increasingly ageing 
population, a shortage of stock both in the property as well as 
healthcare sectors, and the potential for high returns in the sector. 
(Keynote, 2008) 
 
The year 2008 witnessed a drop in revenues for care homes, 
primarily due to the impact of recession, resulting in tightening 
budget spend by consumers as well as tightening financials for care 
homes; however, going forward, the sector is expected to witness a 
healthy rise, growing at a CAGR of 7.3% over the period 2008-
20121. 
Consolidation (resulting in higher prices paid and shortage of 
supply), and an ageing UK population are the key drivers for the UK 
care home market, going forward; these coupled with rising fee rates 
(in both private and local authorities) and an increase in capital value 
is expected to provide further impetus to the sector. (Keynote, 2008) 
 
 
 
 
10.7 11.0 11.6 11.8
12.7
11.4 12.2
13.1 14.0
15.1
2003 2004 2005 2006 2007 2008 2009E 2010E 2011E 2012E
CAGR: 4.4% 
CAGR: 7.3% 
UK Care Home Market Size 
(£ billion, 2003 ± 2012) 
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6RXUFHµ8.3ULYDWH+HDOWKFDUH¶.H\QRWH   
 
8.¶V FDUH KRPH PDUNHW LV GRPLQDWHG E\ the private sector, accounting for about 68% share in 
2007; its share has risen from about 63% in 2003, primarily due to the entry of new players, as 
well as inorganic expansion of major care home providers, which have eaten into the share of the 
public sector care homes (dropped from 21% in 2003 to 18% in 2008)1. (Keynote, 2008) 
 
 
 
 
 
 
UK Care Homes Market Size, BY Segment  
(% 2007) 
100% = £12.7 billion 
Voluntary 
Sector
14%
Public 
Sector
18%
Private 
Sector
68%
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6RXUFHµ8.3ULYDWH+HDOWKFDUH¶Keynote (2008)   
 
 
South Eastern, North West, and South West are the three largest markets in the UK, accounting for 
23% of total number of beds in 2008. Keynote (2008)   
 
In the regional UK care home market, typically bed capacity is inversely proportional to 
occupancy rates as well as public funding. 
 
# Region   No. of Beds   
 Occupancy 
Rate Public Finding 
1 South Eastern   61,122 91% 43.20% 
2 North West   51,339 90% 62.50% 
3 South West   43,332 92% 47.50% 
4 Scotland   37,955 93% 67.90% 
5 Eastern   37,208 93% 49.40% 
6 Yorkshire & Humberside   37,192 88% 59.30% 
7 East Midlands   34,344 87% 55.80% 
8 West Midlands   33,335 92% 62.60% 
9 Northern Home Counties   31,947 93% 49.90% 
10 Greater London   27,023 89% 64.20% 
11 North   26,657 88% 75.90% 
12 Wales   22,806 94% 69.00% 
13 
Northern Ireland & Isle 
of Man   12,932 93% 80.80% 
Average 91% 56.60% 
Number of Beds, Occupancy Rates and Share of Public Funding in the UK 
(units, %, %, 2008) 
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South Eastern (61,122 beds) and South West (43,332) are two of the three largest markets for care 
homes in the UK, accounting for 23% share of total number of beds in 2008. However, while the 
Southern region comprises a major share of the market, they have the lowest proportion of 
occupied care beds supported by public funds, below the sector average of 56.6%. Likewise, while 
Wales, and Northern Ireland account for the least bed capacity, they benefit from high government 
funding as well as high occupancy rates. 
 
In 2008, occupancy rates in the two regions were 94% and 93% respectively, higher than the sector 
average of about 91%. 
 
 
4.2.2. Care Homes by Ownership and Type of Care 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6RXUFHµ8.3ULYDWH+HDOWKFDUH¶Keynote (2008)  
 
The private and voluntary care home sectors are dominated by residential care homes, accounting 
for 53% and 76% share respectively in 2007.  
 
The independent sector (private and voluntary) accounted for about 88% of total beds in the UK 
care home market in 2007, of which the private sector alone accounted for a dominating 74% 
share. 
Public Voluntary Private 
UK Care Home Market, Number of Beds (2007) 
100% = 344,999 100% = 66,300 100% = 56,600 
Nursing 
Care
47%
Resident
ial Care
53%
Nursing 
Care
24%
Residenti
al Care
76%
Nursing 
Care
34%
Resident
ial Care
66%
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Both private and voluntary care homes are dominated by residential care, together accounting for 
57% of the independent care home market in 2007; in the voluntary sector, residential care 
accounts for three-fourths of the total number of beds2. (Laing and Buisson, 2007) 
 
Both, the private and voluntary sector, have witnessed a rise in share of residential care homes as 
local authorities increasingly look to purchase services from cheaper alternatives. 
 
According to Laing & Buisson, average cost per resident per week for nursing care homes (£665) 
is about 18% costlier than that of resident care homes (£566), due to the number of qualified staff, 
FRPSOH[QDWXUHRIUHVLGHQWV¶UHTXLUements, and the overall size of the home2. (Laing and Buisson, 
2007) 
 
In the public sector, local authority homes dominate the total number of beds, with 66% of total 
beds in the sector; all homes in the public sector provide complete nursing care with qualified 
nurses in constant attendance. 
 
³Within the private sector, there has been significant transfer from nursing to residential provision 
over the past few years, as local authorities have sought to make placements in less expensive 
residential care ratKHUWKDQLQQXUVLQJFDUH´ ± William Laing, CEO, Laing & Buisson (2008)  
 
 
 
 
 
 
 
 
Total number of beds has witnessed a period of continuous decline since the early 1990s, primarily 
due to an over-expansion pre 1993. 
Despite an increasing ageing UK population, the number of care home beds in the UK has 
witnessed a continuous decline since the mid 1990s, across all three sectors (private, voluntary, 
and public). A key reason for this decline is the over-expansion in the market up until 1993, a 
period in which the open-ended state-funded income support system generously supported the care 
346.1 346.7 339.7 341.1 344.9
64.7 67.8 67.8 66.3
70.9 67.2 62.5
71.9
59.1 56.6
2003 2004 2005 2006 2007 2008
Private Sector Voluntary Sector Public Sector
488
.9 
478
.6 
470 468 467
.8 
461 
47.4% 48.5% 49.4% 49.9% 50.0%
51.5% 50.6% 50.1% 50.0%52.6%
2003 2004 2005 2006 2007
Nursing Care
Residential Care
UK Care Homes, Split by Home Type 
(%, 2003-2007) 
 
UK Care Homes, Number of Beds 
µ-2007) 
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Self 
Financed
39%
NHS
6%
Local 
Authorities
55%
home sector. However, post 1993, with authorities taking over financing of care homes, tighter 
restrictions implemented on financial eligibility resulted in a continuous bed capacity reduction in 
the care home market. While the overall bed capacity continues to decline, the private care sector 
witnessed a resurgence in total bed capacity post 2005, driven primarily by rising demand from an 
ageing UK population. Both, 2006 and 2007 witnessed an increase of 1,400 and 3,800 beds 
respectively in the private care sector, post a drop of 7,000 beds in 2005. 
 
The public and voluntary sectors, however, continued to witness a drop in capacity till 2008; the 
public sector witnessed an annual average bed capacity drop of about 20% over the period 2003-
2007. Going forward, a continued reduction in the number of care home beds is expected over the 
next five years, primarily due to a decrease in the public sector4. 
 
While long term demographic changes are likely to lead to an increase of care bed provision, it is 
not expected to occur until after 20124.  
 
4.2.3. Means of Care Funding 
 
Social care in the UK is funded through central government funds allocated to the local council; 
FRXQFLO WD[ UHYHQXHV LQGLYLGXDOV¶ FRQWULEXWLRQV WR WKHLU FRXQFLO FDUH SDFNDJH DQGRU WR VHUYLFHV
arranged independently; and voluntary funding. There are national rules for residential care ± an 
individual with assets of more than £22,250 (in 2008/9) is not allowed to receive public financial 
support. The current system for funding adult social care in England has been criticized as unfair, 
complex and financially unsustainable; key issues concerning local authority funding include 
unfairness, lack of transparency, multiple funding streams and age-related funding.  
 
Local authorities remain the main source of 
funding, supporting 206,000 older and 
physically disabled residents in independent 
sector care homes (55% of the total) in 2008, as 
well as 31,000 residents in their own, in-house 
provision. 
 
Nearly all private payers are accommodated in 
independent (private and voluntary) care homes, 
where they account for as many as 39% of the 
376,000 residents. Share of self pay in the 
independent sector has witnessed a continuous 
increase over the period 2003-2008, growing 
from about 33% in 2003.  
 
The remaining residents of private and 
voluntary homes, plus the 42,000 residents in council run homes and long stay NHS hospitals, are 
nearly all paid for by the state ± either by local councils (the majority) or by the NHS. In 2008, 
about 146,000 care home residents in the UK paid their fees privately, accounting for 35% of the 
418,000 care home residents (independent plus public). 
UK Care Homes Funding in Independent 
Homes, By Source  
(% no. of beds, 2008) 
100% = 376,000 
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Low level public sector funding and 
inadequate fees provided by local 
authorities is a key issue, impacting the 
demand for care homes in the UK; in 
the period 2003-2007, both residential 
as well as nursing homes witnessed a 
sharp fall in local authority funding 
The NHS is a rapidly growing source of 
funding for independent sector care 
homes; by 2007 it was estimated to pay 
for 37,000 residents of nursing homes 
across the UK (28% of all independent 
sector nursing care residents) 
 
However, the NHS share falls to only 
10% of independent care home residents 
overall, since no residents in receipt of 
residential only are NHS funded 
 
While the role of private payers in 
residential homes has risen over the 
period, their funding to nursing homes 
have witnessed a fall over the period 
2003-2007 (from 37% to 28%)1. 
(Keynote 2008) 
 
 
 
 
6RXUFHµ8.3ULYDWH+HDOWKFDUH¶Keynote (2008)  
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4.3. Key Trends 
4.3.1. Rise in Demand Post 2010 
 
 
 
 
 
 
Source: Laing and Buisson (2007, 2008) 
 
As of 2008, about 421,000 people were residing in care homes, with 
a majority living as permanent residents; a dominant 89% (373,000) 
resided in the independent sector (private and voluntary) care homes, 
with the remaining 11% (48,000) in public sector provision. Running 
against the tide of population ageing, the number of residents in care 
homes has witnessed a steady decline over the period 1996-2006 
(about 504,000 residents in 1996 to about 421,000 in 2006), 
primarily due to the increasing availability of non-residential 
alternatives (such as Extra Care Housing), as well as funding issues 
by local authorities. However, post a decade of decline, 2007 
recorded no decrease in the number of residents living in care 
homes, indicating resurgence in demand for care homes in the UK4. 
(Laing and Buisson, 2008) 
Going forward, according to Laing & Buisson, volume of care home demand in the UK is 
expected to decrease marginally over the next four years (from 420,000 occupied places in 2008, 
to about 414,000 by 2011), primarily due to a decline in public sector supply.. 
Share of the public sector in total demand is expected to drop from 11% in 2008 to about 7% by 
2012, and a further 6% by 2015, as local authorities and the NHS aim to withdraw from the supply 
(though not funding) of long term care. However, post 2011, total demand is expected rise at a 
CAGR of about 1.2% till 2015 (about 434,000 beds), driven by a high growth in supply within the 
independent sector, expected to offset the rapid decline in public care home provision3. (Laing and 
Buisson, 2008) 
The independent sector care homes are projected to increase from 374,000 in 2007 to 378,000 by 
2012 and 403,000 by 20154. (Laing and Buisson, 2008) 
Period of re-growth in demand  
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
469 466 449 445 435 423 421 421 421 419 417 414 414 421 427 434 
8.&DUH+RPHV'HPDQGµ-2015) 
 
 
 
Care home demand, 
dominated by the 
independent sector, is 
expected to witness 
growth post 2010, after 
a 14 year period of 
continuous decline 
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Projected Demand for Elderly Care5 
 
6RXUFH7KH/DLQJ	%XLVVRQ³&DUH2I(OGHUO\3HRSOH´8.0DUNHW6XUYH\ 
4.3.2. Ageing UK Population 
 
A rapidly growing 65+ year-old population in the UK is expected to drive demand for care 
homes in the long term. 
 
8.¶V UDSLGO\DJHLQJSRSXODWLRQ LVRQHRI WKH
key drivers for care home demand in the 
country, as currently over 1% of the 65-74 
year old population and over 20% of the 85 
and over population live in care homes 
(either private, voluntary or public). 
The number of people aged 65 years and 
over is expected to rise by nearly 60% in the 
next 25 years - from 9.9 million in 2008 to 
over 15 million in 2031; subsequently, the 
percentage of the total population over 65 is 
predicted to rise from 16% in 2008 to about 
22% in 2031, and about 26% in 2071. 
(National Statistical Office, 2009) 
 
 
 
 
 
 
 
 
9.9 10.5
12.9
15.8
17.6 18.7
20.4 21.3
22.9
16% 17% 19%
22% 24% 24%
26% 26% 27%
2008 2011 2021 2031 2041 2051 2061 2071 2081
65+ Population % of Total Population
UK 65+ Population, % of Total Population 
(million, %, 2008-2081) 
 
Source: UK Government Actuary Department; National 
Statistical Office 
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The number of people over 85 in the UK is 
predicted to double in the next 20 years 
and treble in the next 30; the total number 
of centenarians (100+ years) is expected to 
rise even more sharply, trebling in the next 
20 years and quintupling in the next 30 
years. 
This sharply rising old population in the 
UK is expected to put major pressure on 
the UK care home market, due to an 
already high occupancy rates (over 90%), 
and a short term decline in total supply of 
care home beds, resulting in a potential 
demand supply gap. 
 
 
In light of this, the UK care home sector is expected to witness increased participation by private 
players as well as greater funds provided by the public sector, in order to reduce the demand 
supply gap, resulting in a growing care home market in the long term. (National Statistical Office, 
2009) 
 
 
 
Fact file for Older People in the UK6 
1.3 1.4
1.9
2.9
3.8
4.9
5.4
5.9
7.0
2.2% 2.3% 2.9%
4.0%
5.1% 6.3%
6.8% 7.2%
8.2%
2008 2011 2021 2031 2041 2051 2061 2071 2081
85+ Population % of Total Population
UK 85+ Population, % of Total Population 
(million, %, 2008-2081) 
Long-term illness 
 
 Over two thirds (69%) of people aged 85 and over in the UK have a disability or limiting long-
standing illness. For those aged 65-74, the figure is 40% and for people aged 75-84, it is 56%  
 37% of people in Great Britain aged 65-74 and 48% of those aged 75+ have a limiting longstanding 
illness  
 Men in the UK can expect to live their last 6.8 years with a disability. For women, the average is 
9.1 years  
Sensory impairment 
 
 In the UK 42% of people over 75 will develop cataracts, and almost 50% will have some symptoms 
of age-related macular degeneration  
 28% of people aged 65+ have difficulties with their eyesight  
 55% of people aged 60+ are deaf or hard of hearing  
Strokes 
 There are over 100,000 first strokes every year in the UK, and 90% of these affect people over 65 
years  
 
Source: UK Government Actuary Department; National 
Statistical Office 
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Source: Phil Rossall, Older People in the UK, Help the Aged (September 2009) 
4.3.3. Rise in demand for Dementia Care  
  
According to Laing & Buisson's Care of Elderly People Survey 2009, the demand for care home 
places is set to grow. The majority of people living in care homes have some form of dementia 
making it the key focus for the sector. It is essential that staff get the training they need to provide 
good dementia care.  
Numbers of older people (taking the conventional definition as aged 65 or over) ± and particularly 
the numbers of very old people (aged 80 and above) ± will increase substantially over the next fifty 
years in all countries covered by this report, although rates of ageing varies greatly between 
countries. In England in 2005, 16% of the population were aged 65 or over and 4% aged 80 or 
over. By 2050 it is expected that the number of people aged 65 or over will grow from 8 million to 
almost 15 million (by which time this number will represent 25% of the projected total 
population), while the number aged 80 or over will grow from 2 million to just over 6 million 
(equivalent to 10% of the total population). 
 
Dementia Prevalence Rates7 
 
Age group  Population with dementia (%)  
 65±69  1.3 
70±74  2.9 
75±79  5.9 
80±84  12.2 
85±89  20.3 
90±94  28.6 
95 and over  32.5 
 
Source: Knapp et al (2007) 
 
 
Mental Health 
 
 1 in 3 people who die aged 65 or over have dementia 
 Nearly 700,000 people are estimated to be suffering from dementia in the UK in 2007 and, by 2025, 
the number is expected to rise to one million. By 2051, it is projected to exceed 1.7 million 
 Dementia affects 1 person in 5 over 80, 1 in 4 over the age of 85 and 1 in 3 people over 90  
 Depression affects 13-15% of people over 65 living in the community, and 40% of older people in 
care homes  
 There were 790 suicides amongst people aged 65+ in the UK in 2006 ± 14% of all suicides amongst 
those 15 and over 
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¾ In 2006, a large survey of BUPA care homes in the UK identified that over two-thirds 
of residents had neurodegenerative diseases such DVGHPHQWLDVWURNHRU3DUNLQVRQ¶V
disease. The survey included both care homes providing nursing care and care homes 
simply offering personal care9. (Owen, Meyer, Bentley, Heath, Goodman, April 2008) 
 
o Eight out of ten residents had at least one form of mental impairment, two-
thirds were diagnosed as incontinent and nearly half were both incontinent 
and unable to move around without help. Importantly, for over 90 per cent of 
residents, medical problems and associated disability, rather than general 
frailty and social needs, instigated the move into a care home, ie their needs 
were primarily health-related rather than social. 
 
¾ As of Q1 2009, 19% of the UK's care home capacity for older people is dedicated to 
dementia care, 11% in homes catering for dementia only and 8% in dedicated units 
within multiclient homes. With the proportion of care home residents with 
diagnosable dementia at 59%, most residents with dementia and cared for in non-
specialist settings that 17% of delivered domiciliary care hours are specifically for 
dementia needs 14. Laing and Buisson (February 2009) 
¾ Addressing actual demand for dementia care beds, 59% of older care home residents 
are believed to have diagnosable dementia. But the proportion where dementia is a 
known cause of admission is much lower, at about 35% of residents according to a 
FHQVXVRI%83$¶V FDUHKRPH portfolio14. 
 
¾ In 2008, Dementia care in care homes was worth £4.7bn (or 36% of the market).14 
Laing and Buisson (February 2009) 
 
 
 
 
 
 
 
Page | 20 
 
4.3.4. Stable Occupancy Rates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Colliers Cre, 2009 
 
Occupancy rates for both nursing and residential care have remained 
stable in the 2003-2008 period, in the 90-94% range10. (Colliers Cre 
2009) 
 
Occupancy levels within both nursing and residential homes have 
remained fairly stable within the 90-94% mark in the period - 1H 03-2H 
08. Going forward, the rapidly ageing UK population is expected to 
increase the average occupancy for both nursing and private homes, 
above the five year average of 93% (2003-2008). 
Moreover, the escalating burden placed on the State in terms of funding 
provision, combined with increasing demand for dementia care, is 
expected to further drive up occupancy rates in the near and long term. 
 
Variation by Size of Care home ± There is stark disparity in occupancy 
levels across different sizes of care home. 
 
 
 By size of care home, nursing homes that have between, 11 to 20 and 41 to 50 beds 
experienced the highest occupancy levels in 2H 2008, whilst residential homes with zero to 
ten beds enjoyed the highest proportion of residents.  
 Nursing homes with between 21 and 30 beds experienced the lowest levels of occupancy in 
the second half of 200810. (Colliers Cre 2009) 
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UK Care Homes Occupancy Rate, by Home Size or 
Number of Beds 
(%, H2 08) 
 
 
 
Occupancy rates for 
both nursing and 
residential care 
have remained 
stable in the 2003-
2008 period, in the 
90-94% range 
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Regional variation in occupancy levels was not as pronounced as in previous years, with the East 
Midlands scoring the highest average levels at 94%, and Greater London the lowest at 90%10. 
 
 
4.3.5. Declining Care Home Closures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Laing & Buisson, 2006-2008 
 
Total number of care home closures has witnessed an annual average drop of about 35% over the 
period 2005-2008.  
 
Care home closures in the UK, which five years ago were taking place at an alarming rate, 
continue to diminish, reducing from 711 homes (12,267 beds) in 2005 to 219 homes (5,368 beds) 
in 20084. 
 
Total number of care home closures witnessed an annual average decline of 
32.5% over the period 2005-2208; subsequently total number of bed 
closures witnessed an annual average decline of about 24% over the same 
period4. 
Gross national attrition rate of the stock of care home beds has reduced to 
1.3%, compared with a maximum attrition rate of 3.8% at the peak of care 
home closures in 20004. 
Furthermore, the downturn in the residential property market in 2008 is 
expected to be a further disincentive for operators of small scale converted 
homes to exit the market, providing further impetus to declining closures. 
The drop in closures reflects higher fee rates and profitability as well as the 
diminished stock of smaller care homes, which are most vulnerable to 
financial pressures. 
As a result of sharply declining closure rates in the UK care home sector, 
UK Care Homes Closures 
(number of homes, April 2005-April 2008 
UK Care Homes Closures 
(number of beds, April 2005-April 2008) 
 
711
323 269 219
2005 2006 2007 2008
12,267
7,461 6,421 5,368
2005 2006 2007 2008
CAGR: - 
32.5% 
 
CAGR: - 32.5% 
 
Of the total 
closures in 2008, a 
majority 73% was 
accounted for by 
the residential care 
sector, up from 
about 63% in 2004 
 
 
 
 
Total number of 
care home 
closures has 
witnessed an 
annual average 
drop of about 35% 
over the period 
2005-2008 
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care home closures are no longer considered a threat to availability of services, other than in a 
handful of locations. 
 
 
4.3.6. Rising Number of New Registries 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Laing & Buisson, 2006-2008 
 
Post a drop in 2006, number of new care home registries in the UK 
have witnessed a rise in 2007 and 2008, driven primarily by rising 
occupancy rates. New care home registrations in the UK have 
witnessed a rise over the period 2005-2008, rising to 114 homes with 
5,552 beds in 2008, from 85 homes (4,442 beds) in 2005, driven 
primarily by rising occupancy rates and unprecedented price rises in 
the sector4. (Laing & Buisson, 2008) 
 
However, while new registries in the UK care home market continue 
to rise, rate of registrations have remained below that of closures, 
both in terms of homes and number of beds, putting pressure on the 
bed supply in the sector. 
Going forward, the near term is expected to see a further increase in 
the new registration rate, as development pipelines in progress feed 
through from several of the larger care groups as well as local 
entrepreneurs 
 
This resurgence in development activity is focused primarily on the 
private pay market, where fee rates are significantly higher than 
those for council supported residents 
 
According to a survey by Laing & Buisson in 2008, 93% of group 
85 80
98
114
2005 2006 2007 2008
4,167 4,146
5,215 5,552
2005 2006 2007 2008
UK Care Homes New Registries 
(number of homes, April 2005-April 2008) 
 
UK Care Homes New Registries 
(number of beds, April 2005-April 2008) 
 
 
Post a drop in 2006, 
number of new care home 
registries in the UK have 
witnessed a rise in 2007 
and 2008, driven 
primarily by rising 
occupancy rates 
 
Within the UK care home 
market, new registries 
have been dominated by 
the nursing homes sector, 
accounting for 54-56% 
share over the period 
2004-2008. 
 
In 2008, number of new 
beds was greater than 
number of closures. 
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RSHUDWRUVKDYHSODQV IRUµQHZEXLOG¶DQGSODQH[WHQVLRQVRQH[LVWLQJ VLWHVFRQFHQWUDWLQJRQ
the strong self funding market and locations where local authorities pay adequate fees. This is to 
further drive new registries in the UK care home market4. 
 
Page | 24 
 
4.4. Competitive Landscape 
4.4.1. Nature of companies 
 
The UK care homes market comprises over 18,500 
homes, dominated by the private sector (accounting 
for over 70% share), followed by the voluntary 
segment with about 19% share. In 2008, the sector 
comprised 344 major profit providers (comprising 
three beds or more) in this sector, and a further 125 
not-for-profit operators; these major providers 
comprised about 5,120 homes, accounting for about 
28% of total care homes and close to 55% of total 
beds in the UK care home market value11. (Deloitte, 
2008)  
 
Of the major providers, for-profit-companies 
(comprising public and private companies, 
individual/partnership run associations, and provident 
associations) accounted for about 50% market share 
in 2008, rising from about 31.7% in 2000, depicting 
high levels of corporatization in the UK care home 
market. 
 
 
Major providers typically provide complete nursing 
home facilities, including qualified nurses in constant 
attendance; in contrast; the residential sector is 
dominated typically by small homes (one to two 
beds), which account for about 90% of the UK 
residential care market.  
 
The last decade has witnessed a continuous decline in number of residential care and nursing homes 
in the UK, driven by factors such as low local authority fee levels, increase in regulations and high 
land value 
 
Publicly Quoted Providers 
 
From a peak of 20 in 1990, the number of UK publicly quoted operators of care homes for older 
people has dropped to only two companies with a full listing on the London Stock Exchange, 
primarily due to a poor profit performance and a share price drop below net asset values for most 
listed companies10. (Colliers Cre, 2009) 
7KHWZRFRPSDQLHVDUH6RXWKHUQ&URVV+HDOWKFDUH8.¶VODUJHVWFDUHKRPHJURXSDQG&DUH8.D
public sector outsourcing company that seeks long-term contract business from local authorities and 
the NHS.  
 
Not-For-Profit Companies 
12 LA homes organisation  
1 Non UK quoted  
235 Private company  
105 Individual/ partnership  
1 Provident association  
113 
2 
Other organisation  
For-Profit Companies 
UK publicly quoted  
Major Providers of Long-Term Elderly 
Care (2008) 
 
 
The UK care home market comprises 344 
profit companies and 125 non-profit 
companies, with only two companies listed 
on the LSE 
 
Source: (Colliers Cre 2009) 
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Going forward as well, most analysts see little prospect for the foreseeable future of a resurgence of 
stock exchange-quoted care home groups. 
 
 
4.4.2. Top Five UK Care Home Players  
 
(As of February 2009) 
 
 
Care Home Operator13 Number of Care Homes Number of Beds EBITDAR/Revenues (2007)10 
Southern Cross Healthcare 727 37,080 29% 
Four Seasons Healthcare 446 21,154 25% 
BUPA Care Homes 302 21,360 26% 
Barchester Healthcare 171 11,290 17% 
Craegmoor  234 4,700 20% 
Source: (Colliers Cre 2009, King Sturge, 2007)  
 
Providers of care homes in the UK range from large for-
profit companies to small businesses and voluntary 
sector/charitable organisations; some local authorities also 
run care homes in the UK. The average care home in the 
UK has about 23 beds, although this conceals a wide 
distribution, from those with only two to three beds to 
homes with over 100 beds. 
The UK care home market is fairly consolidated at the top end, with the top five players 
accounting for about 22% of beds (growing from about 15% in 2003) and 10% of number of 
homes in 200811. (Deloitte, 2008) 
At the bottom end, the market is highly fragmented, with a significant number of homes owned 
and operated individually, and comprising one or two beds; the next ten players accounted for 4% 
of the total number of beds in 200811. $PDMRULW\RIWKHPLGGOHPDUNHWRSHUDWRUVDFWDV³IHHGHUV´
for the large groups, repeatedly developing and selling smaller groups; their strategy is typically to 
build up a sizeable business through the acquisition of individual homes or small groups with the 
aim of a multiple arbitrage upon exit, most likely to one of the larger players. 
The bottom end of the market as witnessed several new entrants, realising equity from the housing 
market and switching from other sectors; however, the lack of stock, level of demand and increase 
in prices has made it difficult for these companies to get low cost ownership assistance. 
 
 
The market is fairly fragmented with 
the top five players accounting for 
22% of total UK care home beds in 
2008 
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Not-for-profit organisations ( voluntary homes) comprised 59,000 care home beds at the end of 
2008, for which about 50,000 were owned by 125 major players (with three beds or more); most of 
them focus on residential rather than nursing care. One of the traditional strengths of not-for-profit, 
voluntary organisations is their experience in working with local authorities, often rooted in shared 
values, a region where private players are still weak11.  
 
A further advantage of not-for-profit organisations is access to capital at a lower cost than what 
for-profit providers have to pay; moreover, in some cases, such as charities, development capital 
may come entirely free from donations. 
 
Going forward, not-for-profit organisations stand to further benefit from their close relationships 
with local authorities, as the latter seek sustainable long term partnerships with independent sector 
bodies to replace their in-house provision of residential care. 
 
 
 
 Concentration of ownership by major players is 
VLJQLILFDQWO\ KLJKHU LQ WKH YROXQWDU\ RU µQRW-for-
SURILW¶ VHFWRU WKDQ LQ WKH SULYDWH VHFWRU PDMRU
providers accounted for about 41% of all non-profit 
care homes and 85% of total beds in 200811. 
 
 However, the market is highly fragmented with the 
largest three players accounting for about 13% of 
total beds, and only 3% of the total number of care 
homes in the voluntary care home market, in 2007. 
 The largest player in the voluntary care home sector 
is Anchor Trust, which operated 100 homes (with 
4,276 beds) in 2007. 
 
 
 
 
 
 
 
 
 
 
Source: Deloitte (July 2008) 
 
 
 
 
 
 
 
The 
Order 
of St 
John 
Trust
Others
87%
Anchor 
Trust
6%
Methodi
st 
Homes 
for the 
Aged
UK Voluntary Care Home Market, Number 
of Beds (%, 2007)11 
100% = 66,300 
The voluntary care home market is highly 
fragmented, with the top three players 
accounting for 3% of total non-profit 
homes in the UK, in 2007. 
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Source: Healthcare Business (July/ August 2008) 
 
 
 
Company Homes Beds 
 Southern Cross   727 37,080 
 Four Seasons Health Care  446 21,154 
 BUPA Care Homes   302 21,360 
 Barchester  Healthcare   171 11,290 
 Craegmoor   234 4,700 
 Bondcare   88 4,892 
 Anchor Trust   104 4,578 
 Caring Homes   117 3,130 
 Order of St John Care 
Trust   74 3,250 
 MHA Care Group   62 2,513 
 Care UK   78 3,170 
 Shaw Healthcare   75 2,352 
 Abbeyfield   85 2,294 
 Leonard Cheshire   99 1,953 
 Exelcare Holdings   37 1,767 
 Sanctuary Care   53 1,630 
 European Care   37 1,600 
 CLS Care Services   38 1,460 
 Quantum Care Ltd   27 1,448 
 Paragon Healthcare   186 1,439 
 Runwood Homes   25 1,438 
 Mimosa Healthcare Group 30 1,416 
 Hallmark Healthcare   24 1,468 
 Somerset Care   43 1,304 
 Meridian   26 1,296 
 Prime Life   44 1,112 
 The Fremantle Trust   43 1,114 
 Prime Life   44 1,111 
 Executive Care Group   23 1,069 
 Maria Mallaband   31 1,046 
 Guardian Care Homes   29 1,033 
 Carebase   14 822 
Top 32 UK Care Home Players, Ranked by Number of Beds12  
(As of February 2009) 
 
 
The top 32 care home 
providers accounted 
for 18% of total care 
homes and 32% of 
number of beds in the 
UK care home market 
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Source: King Sturge, 2007; Company Websites  
 
The care home market in the UK has seen a significant move over recent years towards the 
consolidation (via acquisitions) of ownership into the hands of fewer and larger ownership 
organisations.  
 
With limited growth achievable through fee rate rises, development acquisition of new beds 
has been a key growth driver for care companies in the UK in the recent past. 
The top four players, including Southern Cross Healthcare Group, BUPA, Barchester 
Healthcare, and Four Seasons Health Care, have been the key drivers for consolidation, 
through acquisitions of leased businesses as well as freehold going concerns.  
 
7KH WRS ILYH SOD\HUV¶ VKDUH RI WRWDO FDUH KRPH EHGV KDV ULVHQ
from 15% in 2003 to 22% in 2008, primarily due to inorganic 
growth11. (Deloitte, Laing &Buisson, 2008) 
 
The primary reason for increasing consolidation is the rising 
attractiveness in the market, due to rising occupancy rates and 
unprecedented price rises; over the past five years, average 
occupancy levels have been in excess of 90%, while over the 
past seven years average fee rates have risen at a faster rate than 
RPI. 
 
However, after a period of rapid consolidation the rate has 
slowed, as the pool of homes suitable and available for corporate 
acquisition has largely been exhausted. 
Top Four UK Care Home Players, Number 
of Homes (June 2003, February 2009)13 
Southern
Cross
Healthcare
Four
Seasons
Healthcare
BUPA Care
Homes
Barchester
Healthcare
June 2003 Fenruary 2009
 
Going forward, with 
declining M&A activity, 
development activity 
has started to increase, 
DVWKH³G\QDPLFV´
increasingly make 
development a viable 
route, and is likely to be 
fuelled further by a 
significant forecasted 
increase in the elderly 
population 
 
 
 
The UK care homes 
market has witnessed 
high levels of M&A 
activity in the recent 
past, predominantly 
by the major players 
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Going forward, future deals within the care sector are likely to be driven by the major 
players, who are keen to continue their consolidation of the elderly and specialist care 
markets by expanding their geographical footprint. 
 
 
 
Date Target & Sector Acquirer 
Enterprise 
Value £m 
Exit Multiple Enterprise Value / 
EBITDA 
Sept-08   Carewatch   Lyceum Capital   37 11.9 times post tax profits for the year 
ending 31 December 2007, representing 
eight times current year EBITDA 
Aug-08   Care 
Aspirations   
GI Partners    N/A   GI Partners paid nine times current year 
EBITDA 
Aug-08   Lodestone 
Patient Care  
Alliance Medical    N/A   N/A   
July-08   Craegmoor   Advent 
International   
 290 
(unconfirmed)  
8.7 times EBITDA as reported in statutory 
accounts to December 2007 
May-08   Beacon Care 
Holdings   
CareTech 
Holdings plc   
22.5 20.4 times historic EBITDA of £1.1 
million for the year ending 30 December 
2006 
Mar-08   The 
Cromwell 
Hospital   
BUPA   90 10.7 times EBITDA of £8.4 million for 
nine months to September 2007 
Mar-08   Cygnet 2002 Cygnet 2008   360 14 times projected EBITDA for 2008 
Feb-08   Classic 
Hospitals   
Spire 
Healthcare/Cinven 
145 Reported to be approximately 14 times 
EBITDA for year end 2007  
Feb-08   Nine 
Nuffield 
hospitals   
General 
Healthcare Group   
140 12.7 times reported current EBITDA of 
£11 million 
Nov-07  Complete 
Care 
Holdings 
Ltd  
Claimar Care 
Group 
33 WLPHVFXUUHQW(%,7'$RIµLQH[FHVVRI
 PLOOLRQ¶ DV UHSRUWHG E\ 6RYHUHLJQ
Capital at the time of sale 
June-07  BUPA 
Hospitals 
Limited  
Cinven  1440 14 times projected EBITDA for the year 
ending 31 December 2007 
 
Source: Community Care Market News (February 2009) 
³There continue to be strong forces driving consolidation in the care home 
PDUNHWDQGZHFDQH[SHFWWKHFRUSRUDWHV¶PDUNHWVKDUHWRFRQWLQue to grow in 
the future. However, the care home sector is still fragmented compared with 
other sectors of the economy. At the current slow rate of development of new 
capacity, small businesses will continue to have a major role for the 
foreseeable future.´± William Laing, CEO, Laing & Buisson (2008) 
 
Recent Acquisitions in the Care Home Market14 
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4.4.3. 
In 2008, Care Quality Commission (CQC) was established by the Health and Social Care 
Act 2008 (HSCA) as the independent health and social care regulator for the UK, and was 
ordained with enforcement powers to act under the HSCA from 1 April, 2009 
The commission will regulate healthcare and adult social care provided by the NHS, local 
authorities, private companies as well as voluntary organisations; it also has the authority 
to protect the rights of people detained under the Mental Health Act. CQC replaced the 
Commission for Social Care Inspection (CSCI), the Healthcare Commission and the 
Mental Health Act Commission, all of which have ceased to operate since the inception of 
CQC15. 
 
With the inception of the CQC, resulting in more stringent operational regulation, as well 
major rises in fines in the UK care home market, small and mid sized players (that 
typically operate on small budgets and unable to meet all regulatory standards) may be 
negatively impacted. 
 
This shall put greater pressure on smaller players and may further fuel consolidation the 
medium term. 
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Key Financial Metrics for Care Homes in the UK 
 
EBITDAR as a Proportion OF Revenue, 2002 H1 - 2008 H2 
 
 
EBITDAR for care homes at an average has been a little above 30% during the 2002-2008 
period. This indicates fairly high profitability for the UK care home sector. 
 
EBITDAR as a proportion of total revenue (net profit) fell for both nursing and residential 
homes in the second half of 2008. Residential homes have consistently outperformed nursing 
homes in terms of profit margin since 2002 H1, although the disparity between the two types 
of home has decreased over recent years.  
Figures recorded for residential and nursing homes in the later half of 2008 demonstrate that 
homes are currently outperforming the six year average, albeit only marginally in the case of 
nursing homes. The average annual profit per bed for nursing homes in 2008 H2 was £8,600, 
whilst beds within residential homes were less profitable at £6,900 per annum. The higher 
weekly fees charged by nursing homes would account for this disparity10. (COLL I ERS 
CRE, 2009) 
 
Ebitdar as a Proportion of Revenue by Region  
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There is some regional variation in profit margin. Care homes examined in the South West 
were the least profitable in 2008 H2, with the average profit margin standing at 25%. Homes 
within the South East enjoyed the highest proportion of net profit, with the average figure set 
at 37%10. (COL L I ERS CRE, 2009) 
 
EBITDA as a Proportion of Revenue across Different Sizes of Care Homes  
 
 
 
 
For both nursing and residential homes those with less than 20 beds were the most profitable 
in 2008 H2, followed by those with over 50 beds. Homes with this high number of beds are 
often owned by large corporate operators who can utilize economies of scale to their full 
advantage. Nursing and residential homes with 21 to 30 beds were the least profitable in 
2008 H2. (COL L I ERS CRE, 2009) 
 
4.4.4. Profiles of Key Players 
 
BUPA Care Home                                
 
Bupa Care Homes is one of the largest care home operator in the UK, offering services 
across 300 care homes in the country. 
 
Headquartered in the UK and established in 1985, BUPA Care Homes is a subsidiary of the 
British United Provident Association. The company has three core business divisions 
including UK Insurance, International Insurance, and Care Homes, and caters to more than 
10 million customers in over 190 countries. The company operates about 430 nursing and 
residential care homes in the UK, Spain, Australia, and New Zealand.  
 
Residential 
Page | 33 
 
%XSD¶V &DUH +RPHV 7KH (OPV ZDV JLYHQ DQ 
([FHOOHQW
 UDWLQJ E\ WKH &DUH 4XDOLW\
&RPPLVVLRQ &4&DOVR LW¶V :HQWZRUWK&URIW FDUH KRPH VFRUHGD 
*RRG
 UDWLQJ DQG ZDV
also rated as the best commercial care home provider by Laing and Buisson (May 2009).   
 
 Bupa also opened a £5 million specialist dementia care home in Thatcham, UK 
(August 2008). 
 
 Bupa acquired the Cromwell Hospital in London for £90 million, as a part its plan to 
create a flagship private hospital (March 2008). 
 
 As a part of its expansion strategy, BUPA plans the opening of more care homes in 
Brighton, Hampshire and Worcestershire in 2009. 
 
 
 
   5HYHQXHV JHQHUDWHG E\ WKH FRPSDQ\¶V
care homes segment (global) grew by 
35% in 2007 to reach to £873.2 million 
in 2008; the underlying surplus stood at 
£123.9 million in 2008. An increase in 
the number of residents and a small fee 
increase from local authorities in the 
UK led to the increase in revenues in 
2008 
 
 
 
 
 
Source: Company Website; Company Annual Report 2008 
 
Key Statistics (February 2009) 
No. of Beds - 32,577 (global); 21,360 (UK) 
Average No. of Residents ± 28,963 (global) 
Occupancy Ratio ± 89.4% 
No. of Sites ± 430 (global); 302 (UK) 
 
Southern Cross Healthcare 
 
Southern Cross Healthcare increased its bed capacity by about 9% in 2008 over 2007, to 
reach a total of 37,080 beds. Southern Cross Healthcare offers a range of care services, 
including nursing, residential and dementia care, and is the market leader in the UK care 
homes sector. Southern Cross Healthcare floated on the stock market in July 2006, and 
was listed on the FTSE 250 index in September 2006  
 
BUPA Care Homes Revenue 
(£ million, 2006-2008) 
873.2
590.5 648.7
2006 2007 2008
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 The company operates through two divisions, Southern Cross Healthcare and 
Ashbourne Senior Living brands, which offers private care homes for the elderly; and 
the Active Care Partnership brand that offers a range of specialist services for people 
with mental health requirements  
 In 2008, Southern Cross acquired Avery Healthcare Ltd for £96.5m, with it gaining 
another 15 homes and 845 beds for its portfolio 
 $V D SDUW RI LWV H[SDQVLRQ VWUDWHJ\ µ1HZ %XLOG 3URJUDP¶ 6RXWKHUQ &URVV SODQV WR
open new care centers across UK 
 The company opened five new care homes, including Birch Tree Manor, Torrwood 
Care Centre, Hamilton House Care Center, Forth View Care Centre, and Lakeside 
Care Centre in the UK (2008) 
 In 2007, the company acquired Focus Healthcare, a care home company with a 
portfolio of 29 care homes (March), and Lifestyle Care, which included 23 homes 
(January) 
 
 
 
 
 
The increase in the number of new beds and a 
higher occupancy rate attributed to the 21.5% 
growth in revenues in 2008 over 2007  
Also, the rise in average weekly fee and a 16.2% 
increase in the number of residents at care homes 
contributed to the revenue growth in 2008 
 
 
 
Key Statistics (February 2009) 
No. of Beds ± 37,080 (in UK) 
Average No. of Residents ± 28,963 
Occupancy Ratio ± 89.5% 
No. of Sites ± 737 
 
Source: Company Website; Company Annual Report 2008 
 
 
 
Four Seasons Healthcare  
 
Four Seasons Healthcare is a leading independent care home provider, with more than 21,000 
beds at over 446 sites in the UK. Established in 1980, Four Seasons Health Care owns and 
operates over 440 nursing and care homes and specialised care centres in the UK, Scotland, 
Northern Ireland and Isle of Man. It is the third largest company in terms of number of beds 
in the UK, after BUPA and Southern Cross. Four Seasons offers its services to about 15,000 
Southern Cross Health Care Homes 
Revenue  
731.9
889.4
2007 2008
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people in its care and nursing homes and specialist units, and employs a staff of over 21,000 
people.  
 
The company also operates nurseries, domiciliary centres, retirement apartments and 
villages, as well as day centres for the elderly. Four Seasons invested about £8 million to 
open a Built Care Home in Edinburgh with more than 60 bed nursing and social care homes 
(June 2009). Recent acquisitions include the Ivy Bank care home in Bath in December 2007 
and, most recently, the Bon Air Care Apartments in St Saviour in Jersey in March 2008. 
Ivybank House provides high quality care for up to 40 residents, aiding the care home in 
increasing its presence in the Bath area. Four Seasons partnered with Age Concern 
Sunderland (ACS), the largest charity working for older people, to offer day services to local 
residents (October 2008). The company jointly with Edinburgh City Council, opened the 
Castlegreen Care Home, offering accommodation to 60 people (December 2007). 
 
 
 
 
7KHFRPSDQ\¶VUHYHQXHLQFUHDVHGE\DERXW
12% in 2007, over 2006 
 
 
 
 
 
 
 
Key Statistics (February 2009) 
No. of Beds ± 21,154 
Average No. of Residents ± ~18,000 
Occupancy Ratio ± 87%  
No. of Sites ± 446 
 
Source: Company Website; Company Annual Report 2008 
 
 
 
 
Barchester Healthcare   
 
Barchester Healthcare provides residential and nursing care homes in about 170 sites in the 
UK. Established in 1993 and headquartered in the UK, Barchester Healthcare is a provider of 
residential and nursing home care. The company caters primarily for self-paying elderly 
residents; it is 50% owned by JES Barchester Holdco, with the ultimate parent company 
being JES Grove. The organisation offers a wide range of care services, including nursing 
Four Seasons Care Homes Revenue 
(£ million, 2006-2007) 
368.9
414
2006 2007
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care for older people and consultant-led nursing care for adults with specialist healthcare 
needs. 
 
 It offers experience in caring for both older and younger people with disabilities and 
provides personalised care and 24 hour assistance to its residents 
 
 Its various care homes offer specialist care for conditions, such as brain injury 
rehabilitation, Huntington's and Parkinson's disease, dementia and physical disabilities.  
 The company opened a new care home for elderly care in north-west Hampshire to 
increase its market presence (June 2009) 
 
 
 
 
 
 
7KHFRPSDQ\¶VUHYHQXHLQFUHDVHGE\DERXWLQ
over 2006. 
 
 
 
 
 
Key Statistics (February 2009) 
No. of Beds ± 11,290 
No. of Sites ± 171 
Barchester Healthcare Revenue 
(£ million, 2006-2007) 
327.9 350.8
2006 2007
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5. Conclusions  
 
Findings of the Market Analysis and Implications for Pfizer UK 
The market analysis of the care homes market indicates the following findings ±  
 
Findings Implications for Pfizer 
 8.¶VUDSLGO\DJeing population is one of the key drivers for 
care home demand, with the number of people aged 65+ 
expected to rise by nearly 60% in the next 25 years, and 
people over 85 predicted to double in the next 20 years. 
 New care home registrations in the UK has witnessed a rise, 
driven primarily by rising occupancy rates and unprecedented 
price rises in the sector, driving care home demand 
 The rapidly ageing UK population is expected to increase the 
average occupancy for both nursing and private homes, above 
the five year average of 93% (2003-2008) 
 Given the large market size of the 
care home market, increasing 
demand, Pfizer can focus more on 
marketing of its established drugs 
to the care home sector as the 
sector represents a significant 
volume market opportunity for the 
commonly prevalent ailments 
such as dementia, cardiovascular, 
respiratory diseases, etc  
 Dementia is a key segment of the care home segment, 
accounting for about 36% of the UK care home market in 
2008. 
 Since Pfizer already has an 
portfolio catering to neurological 
drugs, growth in dementia makes 
the UK market as an attractive 
growth segment for Pfizer 
 The care home sector has witnessed strong growth with key 
players having witnessed double digit revenue growth rates in 
recent years. 
 The average EBITDAR for the sector has been above 30% 
indicating strong profitability 
 The consolidation in recent years has indicated that the larger 
players are looking to grab a greater share of the market. 
 Still, the high fragmentation in the sector indicates ample 
room for consolidation and inorganic growth 
 With the formation of Care Quality Commission in 2008, 
stricter government rules will put greater pressure on smaller 
operators and further increase scope for consolidation 
 The fragmented nature of the 
market, attractive margins, and 
potential for strong top line 
growth indicates makes the care 
home market as an attractive area 
for a horizontal diversification 
strategy in the UK 
o While pharmaceutical 
companies entering into the 
healthcare services space is 
not very evident in Europe, 
emerging markets with 
demographic drivers such as 
India have witnessed 
combined business models 
(such as Ranbaxy/ Fortis and 
Wockhardt) where pharma 
companies have entered the 
healthcare services sector 
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